Biomatter
Last verified 2026-05-17. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $7.0Mattributed |
|---|---|
| Latest round | seed, $7.0M, 2024-08-28attributed |
| Founded | 2018 |
| Headquarters | Vilnius |
| Industry | bio |
| Stage | seed |
| Website | biomatter.ai |
Generative-protein-design platform that engineers proteins for industrial enzymes, materials, and therapeutic candidates. Sold to industrial biotech, food, and pharma companies that need custom protein performance. Bills itself as protein architects bridging AI and synthetic biology.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-08-28 | seed | $7.0M | undisclosed |
Detected tech stack
LiteSpeed, PHP 8.1.34, LiteSpeed Cache, Google Analytics, Google Tag Manager, DoubleClick Floodlight, Hostinger, WordPress, Shopify, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $7.0M | attributed | eu-startups named as publisher. No document URL on file. |
| Total raised $7.0M | attributed | eu-startups named as publisher. No document URL on file. |
| Company existence | self-reported | biomatter.ai, read 2026-05-17 |
| Description | self-reported | biomatter.ai, read 2026-05-17 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.